A branch of the Second Avenue Deli is opening an upstairs bar where you can raise a toast (using a Dr. Brown’s) to Jewish culture.
NYS Entity Status
NYS Filing Date
NOVEMBER 01, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - BENALEX PHARMACEUTICALS, INC.
Around the Web
- A Deli Where Rye Comes in Slices and in a Glass
By ROBERT SIMONSON - Wednesday Nov 15, 2017
- What to Do When You’ve Picked the Wrong Suburb
By BROOKE LEA FOSTER - Friday Jul 28, 2017
After leaving the city, some people discover that the first town they choose isn’t quite right and they have to search for a place that is a better fit.
- A Drug Maker Spends Big in Washington to Make Itself Heard
By JAY HANCOCK, ELIZABETH LUCAS and SYDNEY LUPKIN - Friday Jul 21, 2017
Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.
- Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
Monday Oct 16, 2017
Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]